Enovis Corp
NYSE:ENOV

Watchlist Manager
Enovis Corp Logo
Enovis Corp
NYSE:ENOV
Watchlist
Price: 43.95 USD 1.71%
Market Cap: 2.5B USD
Have any thoughts about
Enovis Corp?
Write Note

Enovis Corp
Investor Relations

Enovis Corp., a company with a steadfast commitment to innovation and growth, operates within the specialized world of medical technology. Originally a part of Colfax Corporation, it underwent a strategic transformation, branching out into its own entity, laser-focused on advancing human mobility through cutting-edge orthopedic solutions. Enovis has carved its niche by developing and manufacturing high-quality, bespoke orthopedic products that serve both surgical and non-surgical needs. These offerings are designed to enhance patient recovery and mobility, thereby improving quality of life. Its extensive product portfolio includes surgical implants, bracing, rehabilitation solutions, and intelligent digital care platforms, positioning Enovis at the intersection of healthcare and technology.

Revenue for Enovis streams from its diverse array of products and solutions targeted at healthcare professionals and institutions worldwide. The company thrives by engaging in both direct sales and a network of distributors to ensure its innovative solutions reach a broad spectrum of the healthcare landscape. By continually investing in research and development, Enovis maintains its competitive edge, launching new products that address evolving medical needs. This proactive approach not only caters to the existing demand but also stimulates new markets by educating and training medical professionals and leading them through transformative, evidence-based clinical outcomes. In essence, Enovis Corp. excels by integrating science and technology to fuel both financial growth and human betterment.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Matthew L. Trerotola
CEO & Chairman
No Bio Available
Mr. Phillip Benjamin Berry
Senior VP & CFO
No Bio Available
Ms. Patricia A. Lang
Senior VP & Chief Human Resources Officer
No Bio Available
Mr. Daniel A. Pryor
Executive Vice President of Strategy & Business Development
No Bio Available
Mr. Brady R. Shirley
Executive Advisor & Director
No Bio Available
Mr. John Kleckner
VP, Controller & Chief Accounting Officer
No Bio Available
Mr. Derek Leckow J.D.
Vice President of Investor Relations
No Bio Available
Mr. Bradley J. Tandy J.D.
Senior VP & Chief Legal Officer
No Bio Available
Katie Sweet
Vice President of Corporate Communication
No Bio Available
Mr. Tim Czartoski
President of U.S. Surgical and Global Product & Enabling Technologies
No Bio Available

Contacts

Address
DELAWARE
Wilmington
2711 Centerville Road, Suite 400
Contacts
+13022529160.0
www.enovis.com